Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Hydroxychloroquine for Primary Prophylaxis Against SARS-CoV-2 in Health-care Workers - a Randomized, Double-blind, Controlled Trial

NCT04336748 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT04336748
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04336748 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Hydroxychloroquine for Primary Prophylaxis Against SARS-CoV-2 in Health-care Workers - a Randomized, Double-blind, Controlled Trial
Lead sponsor
Medical University of Vienna
Phase
Phase 3
Overall status
Withdrawn
Start date
April 30, 2020
Completion date
August 31, 2020
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthcare worker, infection viral, prophylaxis, sars-cov2